“Never Events” Spur Medical Device Innovation
This article was originally published in Start Up
Executive Summary
Start-ups developing technologies to help hospitals avoid preventable medical errors known as “never events” are developing solutions to nosocomial infections, retained surgical objects, pressure ulcers, and medication errors.
You may also be interested in...
Stryker In Neverland: Firm Ups Focus On Averting Avoidable Events With Sage Acquisition
Stryker will pay nearly $2.8 billion to buy Sage Products and its portfolio of products to prevent health care "never events," which hospitals are increasingly motivated to avoid.
Immunexpress Aims To Leverage Anti-Infection Incentives For Sepsis Diagnostic
Immunexpress' SeptiCyte system is designed to directly quantify molecular markers of sepsis from patient blood samples and within a few hours detect the probability that a patient has sepsis, allowing for aggressive treatment, or if the test result is negative, preventing unnecessary antibiotics.
Immunexpress Looks To Leverage U.S. Anti-Infection Incentives With Unique Sepsis Diagnostic
The Seattle company's SeptiCyte system is designed to directly quantify molecular markers of sepsis from patient blood samples and tell doctors the probability that a patient has sepsis within four hours, allowing for aggressive treatment of sepsis or, if the test result is negative, preventing unnecessary antibiotics.